# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-048318
Filing Date
2024-04-25
Accepted
2024-04-25 16:11:37
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tern-ars-2023.pdf | ARS | 805714
| Complete submission text file | 0000950170-24-048318.txt |  | 1109087

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39926 | Film No.: 24876408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)